comparemela.com
Home
Live Updates
HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP
HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP
HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST
/PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced an exclusive licensing agreement with Bioprojet to develop, manufacture and...
Related Keywords
France ,
Paris ,
France General ,
United States ,
French ,
American ,
Luis Sanay ,
Pitolisant Wakix ,
Jean Charles Schwartz ,
Jeffreym Dayno ,
Prnewswire Harmony Biosciences Holdings Inc ,
Exchange Commission ,
Drug Administration ,
Paragon Biosciences ,
Nasdaq ,
Biosciences Holdings ,
Harmony Biosciences President ,
Professor Jean Charles Schwartz ,
European Academies ,
Latin American ,
Harmony Biosciences ,
Plymouth Meeting ,
Full Prescribing Information ,
Private Securities Litigation Reform Act ,
Annual Report ,
Biosciences Investor Contact ,
Biosciences Media Contact ,